Skip to Main Content
Our Commitment to Diversity

Genesis Healthcare and the 340B Program Patient Definition

Share via LinkedIn
Share via Twitter
Share via Facebook
Date: 9 August 2022
Triage
By: Andrew D. Ruskin, Leah D'Aurora Richardson, Victoria K. Hamscho

In this episode, Andrew Ruskin, Leah Richardson, and Victoria Hamscho analyze the U.S. Court of Appeals for the Fourth Circuit’s recent decision in Genesis Healthcare v. Becerra. They discuss its potential impact on the Health Resources and Services Administration’s definition of a 340B eligible patient in light of recent developments in the 340B Program and this year’s upcoming election. 

Andrew D. Ruskin
Andrew D. Ruskin
Washington DC
Leah D'Aurora Richardson
Leah D'Aurora Richardson
Research Triangle Park
Victoria K. Hamscho
Victoria K. Hamscho
Washington DC
Find more items tagged as: Health Care and FDA, Health Care Payor-Provider Disputes (U.S.), Health Care Sector, Health Care Transactions, Policy and Regulatory
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel